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Preoperative Red Cell Distribution 
Width and 30-day mortality in older 
patients undergoing non-cardiac 
surgery: a retrospective cohort 
observational study
H. R. Abdullah  1, Y. E. Sim2, Y. T. Sim3, A. L. Ang4, Y. H. Chan5, T. Richards6 & B. C. Ong7
Increased red cell distribution width (RDW) is associated with poorer outcomes in various patient 
populations. We investigated the association between preoperative RDW and anaemia on 30-day 
postoperative mortality among elderly patients undergoing non-cardiac surgery. Medical records 
of 24,579 patients aged 65 and older who underwent surgery under anaesthesia between 1 January 
2012 and 31 October 2016 were retrospectively analysed. Patients who died within 30 days had higher 
median RDW (15.0%) than those who were alive (13.4%). Based on multivariate logistic regression, in 
our cohort of elderly patients undergoing non-cardiac surgery, moderate/severe preoperative anaemia 
(aOR 1.61, p = 0.04) and high preoperative RDW levels in the 3rd quartile (>13.4% and ≤14.3%) and 
4th quartile (>14.3%) were significantly associated with increased odds of 30-day mortality - (aOR 
2.12, p = 0.02) and (aOR 2.85, p = 0.001) respectively, after adjusting for the effects of transfusion, 
surgical severity, priority of surgery, and comorbidities. Patients with high RDW, defined as >15.7% 
(90th centile), and preoperative anaemia have higher odds of 30-day mortality compared to patients 
with anaemia and normal RDW. Thus, preoperative RDW independently increases risk of 30-day 
postoperative mortality, and future risk stratification strategies should include RDW as a factor.
Red cell distribution width (RDW) is an automated measure of the heterogeneity in erythrocyte sizes and is rou-
tinely performed as part of a Full Blood Count1,2. An increase in RDW, termed anisocytosis, reflects increased 
variation in the sizes of red blood cells (RBC) attributable to the presence of small and large RBCs, or both. 
Anisocytosis can be acquired, from nutritional deficiency such as iron (small RBC), vitamin B-12 and folate 
deficiency (large RBC), or in anaemia of chronic disease. RDW can also reflect underlying diseases such as in 
haemolytic anaemia and clinically significant thalassemic syndromes3,4. Traditionally, RDW has been used with 
other red cell indices (such as Mean Corpuscular Volume), to provide clues for underlying causes of anaemia, 
such as nutritional deficiencies and clinically significant thalassemia. More recently however, there is increasing 
interest in the role of RDW as a biomarker for inflammatory states and as a prognostication tool, with accumu-
lating studies demonstrating increased RDW as an independent predictor for poorer outcomes among patients 
with ischaemic heart disease5–8, cardiac failure9,10, cerebrovascular disease11,12, cancer13,14 and patients who are 
critically ill in the Intensive Care setting15. More importantly, a number of studies have demonstrated a strong 
correlation between RDW and mortality in the older population16–18. Although the exact mechanisms remains 
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unclear, given that higher RDW is associated with advancing age3,10 and higher disease burden3,13, RDW may 
serve as a novel biomarker that reflects multiple physiological impairments related to aging.
In the perioperative setting, increased RDW has also been found to be associated with long term outcomes 
such as one-year mortality19,20. Its association with shorter term outcomes such as 30-day mortality remains to 
be elucidated. With increasing proportion of elderly patients presenting for surgery, postoperative complications 
and patient outcomes are a major concern21–23. Consequently, there is a need to identify significant perioperative 
risk factors that allow accurate risk stratification for short term outcomes such as mortality and morbidity. This 
could facilitate meaningful informed patient consent and shared decision-making as well as facilitate targeted 
perioperative risk mitigation strategies24,25. Given that the RDW is routinely reported as a component of the Full 
Blood Count and is readily available for most patients undergoing surgery, understanding its prognostic potential 
could be very valuable and cost effective.
We aim to investigate the association between preoperative RDW and 30-day mortality among the elderly 
patients undergoing non-cardiac surgery and hypothesize that there is a significant association between increased 
RDW and 30-day mortality. Additionally, as anisocytosis is closely related to the presence of anaemia, we aim to 
explore the impact of anaemia on the relationship between RDW and 30-day postoperative mortality.
Methods
Data source. We retrospectively analysed the electronic medical records of 27053 patients aged 65 and older 
who underwent surgery under general or regional anaesthesia between 1 January 2012 and 31 October 2016 in 
Singapore General Hospital, a 1700-bedded tertiary academic hospital in Singapore. Institutional Review Board 
approval was obtained (Singhealth CIRB 2014/651/D) prior to the start of the study and the study was performed 
in accordance with relevant guidelines and regulations. Due to the retrospective nature of the review, waiver of 
informed consent from the patient was approved by the CIRB. Clinical records were sourced from our institu-
tion’s clinical information system (Sunrise Clinical Manager (SCM), Allscripts, IL, USA) and stored in our enter-
prise data repository and analytics system (SingHealth-IHiS Electronic Health Intelligence System - eHINTS), 
which integrates information from multiple healthcare transactional systems including administration, clinical 
and ancillary systems. Mortality data on the system was synchronized with the national death registry records, 
ensuring a complete follow-up. We excluded patients who underwent cardiac surgery, neurosurgery, transplant 
and burns surgery due to their categorically higher blood transfusion requirement and mortality rate. Only the 
outcome of the index surgery was evaluated if a patient underwent multiple surgeries during the data collection 
period. Our final dataset comprised of 24579 patients (Fig. 1).
Data collected include patient demographics as well as preoperative comorbidities - ASA-PS score, previous 
cerebrovascular accidents (CVA), ischemic heart disease (IHD), congestive cardiac failure (CCF), diabetes melli-
tus (DM), Revised Cardiac Risk Index (RCRI) score26, chronic kidney disease and preoperative anaemia. Priority 
of surgery (emergency or elective) and surgical risk classification based on the 2014 ESC/ESA guidelines27,28 were 
recorded as well. Operative data included type of anaesthesia received, perioperative blood transfusion and need 
for reoperation within 30 days of the index surgery. There was incomplete data in the clinical database on condi-
tions associated with raised RDW, such as iron deficiency, vitamin B12 or folate deficiency and myelodysplastic 
syndrome, hence these were not included in the analysis.
Figure 1. Study recruitment flow. Flowchart of Cohort Derivation. GA = general anesthesia; RA = regional 
anaesthesia.
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Procedures and definitions. Full Blood Count were done in our institution’s College of American 
Pathologists accredited laboratory with Sysmex XN Automated Hematology Analyzer (Sysmex Corporation, 
Kobe, Japan) and Advia 2120i Hematology System (Siemens Healthcare Diagnostics Inc, USA). Preoperative 
laboratory results were taken as the latest blood results taken within 90 days before the surgery, and up to the day 
of surgery but before the start time of surgery. These results include the preoperative haemoglobin, red blood cell 
distribution width levels and serum creatinine levels. Anaemia was defined by the World Health Organisation 
(WHO)’s gender-based classification of anaemia severity29. Mild anaemia is defined as haemoglobin (Hb) 
11–12.9 g/dL in males and 11–11.9 g/dL in females; moderate anaemia Hb 8–10.9 g/dL and severe anaemia Hb 
<8.0 g/dL. RDW is reported as a coefficient of variation (percentage) of red blood cell volume with the normal 
reference range for RDW in this hospital laboratory to be 10.9% to 15.7%.
Perioperative blood transfusion was defined as red blood cell (RBC) concentrate units given during the sur-
gery and up to one month after the date of surgery. Pre-existing chronic kidney disease was defined based the 
estimated glomerular filtration rate (eGFR) that is derived from the latest preoperative serum creatinine levels by 
the MDRD equation according to KDIGO guidelines30. The individual components of RCRI were defined as per 
the original study by Lee et al.26.
Statistical analysis. Statistical analysis was done in IBM SPSS Statistics v21.0. We compared the demo-
graphic and perioperative variables between patients who are alive or dead within 30-days of surgery, and across 
RDW quartiles. We checked continuous variables such as age for normality. For continuous, non-parametric var-
iables, the Mann-Whitney U test was used to test for a significant difference in median values between 2 groups, 
and the Kruskal Wallis for a significant difference in median values across more than 2 groups. For categorical 
variables, Chi-square test was used to compare the percentages between the groups.
Multivariate logistic regression was performed to determine independent predictors for 30-day mortal-
ity adjusted for demographic, perioperative clinical risk factors, surgical factors as well as RDW quartiles. We 
checked for multi-collinearity between surgical risk, ASA score and RCRI with the Spearman correlation analysis. 
We plotted the AUC for RDW in predicting 30-day mortality in our patient cohort as well as the test statistics for 
RDW at regular cut-off levels – 13%, 14%, 15%, 16% and 17%. In addition, to explore the interaction between 
RDW and anaemia, we repeated the logistic regression for 30-day mortality with anaemia stratified by the pres-
ence of elevated RDW. We took a RDW cut-off of 15.7%, with values above it considered to be elevated. An RDW 
value of 15.7% corresponds to 90th centile of our population, and is also our laboratory cut-off for the upper limit 
of normal. We performed bootstrapping to assess the influence of missing data on the stability of the results. The 
p values of both results are very consistent, and the p-values that were significant on the multivariate analysis 
remained significant at p < 0.046.
Results
Patient demographics and characteristics. The baseline characteristics of our study cohort is presented 
in Table 1. 348 (1.42%) patients died within 30 days of their index surgery. The median age of those who survived 
up to 30-days after surgery was 72.0, and is significantly lower (P < 0.001) compared to those who died within 
30-days (77.0 years). A significantly (p < 0.001) higher proportion of patients who underwent emergency surgery 
died within 30-days (5.2%) compared to 0.6% in those who underwent elective surgery. The incidence of mor-
tality increased with increasing units of perioperative blood transfusion from 0.9% in those who did not receive 
transfusion, to 10.6% in those who received 2 or more units. Similarly, incidence of mortality increased progres-
sively with increasing severity of anaemia, from 0.5% in the non-anaemics to 4.6% in those with moderate/severe 
anaemia. Moreover, the median RDW levels were also significantly higher in those who died (15.0) compared to 
those who were alive (13.4), P < 0.001.
RDW and 30-day mortality. A comparison of the cohort across the various RDW quartiles is shown in 
Table 2. There were disproportionately more patients in the 4th RDW quartile with higher ASA PS (4&5), mod-
erate/severe preoperative anaemia, received perioperative blood transfusion of 2 units or greater, higher RCRI 
scores (4&5), higher stages of chronic kidney disease (4&5) as well as those who died within 30 days after surgery.
Multivariate analysis. Based on multivariate logistic regression analysis, high preoperative RDW levels 
within 3rd quartile (OR 2.12, 1.13–3.99, p = 0.02) or 4th quartile (aOR 2.85, 1.57–5.17, p = 0.001) were independ-
ent risk factors for postoperative 30-day mortality in our cohort of elderly patients who underwent non-cardiac 
surgery. Other independent predictors of 30-day mortality were older age 76 years and above (aOR 2.41, 
1.61–3.63, p < 0.001), Malay ethnicity (aOR 1.88, 1.17–3.02, p = 0.01) emergency surgery (aOR2.99, 2.15–4.14, 
p < 0.001), repeat surgeries within 30 days (aOR 2.29, 1.51–3.45, p < 0.001), perioperative blood transfusion of 
1 unit (aOR 1.72, 1.15–2.58, p = 0.009) or 2 or more units (aOR 2.50, 1.51–4.14, p < 0.001), increasing ASA-PS 
score (3 or higher), presence of moderate/severe preoperative anaemia (aOR 1.61, 1.03–2.52, p = 0.04), history 
of ischaemic heart disease (aOR 1.70, 1.22–2.36, p = 0.002) and grade 4/5 chronic kidney disease (aOR 2.00, 
1.29–3.10, p = 0.002). The results of univariate and multivariate analyses are shown in Table 3. Based on spearman 
correlation analysis, ASA and Surgical Risk category had high degree of correlation with a R of 0.742; ASA and 
RCRI had a weak correlation with R of 0.384; Surgical risk category and RCRI had negligible correlation with R 
of 0.079 (all P values <0.01). However, all 3 variables were included in our multivariate analysis as we feel that the 
degree of invasiveness and extent of the surgery is a very relevant clinical predictor.
Performance of RDW in predicting 30-day mortality. As patients with each progressive RDW quar-
tiles showed progressively increasing aOR of 30-day mortality compared to patients with RDW levels in the first 
quartile, we plotted the ROC for RDW in predicting 30-day mortality is shown as Figs 2 and 3. The area under 
the curve (AUC) was 0.761 (95% CI; 0.736–0.787). Furthermore, we calculated the sensitivity, specificity, and 
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predictive values for 30-day mortality with incremental RDW values as shown in Table 4. The higher the RDW 
value, the lower its sensitivity and negative predictive value. However, specificity and positive predictive value 
increased with increasing RDW. Our chosen cut-off value of 15.7%, based on the upper limit of the range of 
normal population values validated in our laboratory, had a sensitivity of 39.5%, specificity of 89.3%, positive 
predictive value of 5.3% and negative predictive value of 99.0%.
Alive in 30 days 
(N = 24, 231)
Dead within 30 
days (N = 348) P-value
Patient demographics
Age, median (IQR) 72.0 (68.0–77.0) 77.0 (72.0–82.8) <0.001
Gender
Male 11471 (47.3%) 200 (57.5%)
<0.001
Female 12760 (52.7%) 148 (42.5%)
Race
Chinese 20695 (85.4%) 270 (77.6%)
<0.001
Malay 1233 (5.1%) 39 (11.2%)
Indian 1103 (4.6%) 18 (5.2%)
Others 1200 (5.0%) 21 (6.0%)
Operation details
Priority of Operation
Elective 19919 (82.2%) 113 (32.5%)
<0.001
Emergency 4312 (17.8%) 235 (67.5%)
Surgical Risk
Low 9632 (39.8%) 96 (27.6%)
<0.001Moderate 13110 (54.1%) 195 (56.0%)
High 1489 (6.1%) 57 (16.4%)
Type of Anaesthesia
GA 17084 (70.5%) 271 (77.9%)
0.003
RA 7147 (29.5%) 77 (22.1%)
Repeat Operation(s) within 30 days
Yes 1432 (5.9%) 64 (18.4%)
<0.001
No 22799 (94.1%) 284 (81.6%)
Perioperative Packed Red Blood Cell Transfusion
0 unit 22088 (91.2%) 206 (59.2%)
<0.0011 unit 1720 (7.1%) 92 (26.4%)
2 or more units 423 (1.7%) 50 (14.4%)
Patient characteristics
ASA-PS
1&2 16112 (69.0%) 43 (14.5%)
<0.0013 6816 (29.2%) 158 (53.2%)
4&5 436 (1.9%) 96 (32.3%)
Preoperative Anaemia
None 14562 (61.1%) 66 (19.4%)
<0.001Mild 5097 (21.4%) 74 (21.7%)
Moderate/Severe 4190 (17.6%) 201 (58.9%)
RCRI scores
0 11288 (62.9%) 33 (15.3%)
<0.001
1 4778 (26.6%) 76 (35.2%)
2 1393 (7.8%) 69 (31.9%)
3 391 (2.2%) 29 (13.4%)
4 89 (0.5%) 8 (3.7%)
5 15 (0.1%) 1 (0.5%)
6 0 0
Presence of Individual components of RCRI
Ischemic heart disease 2619 (15.1%) 93 (43.5%) <0.001
Previous Cerebrovascular accident 1023 (5.9%) 33 (15.3%) <0.001
Diabetes mellitus on insulin 831 (4.6%) 27 (12.3%) <0.001
Congestive cardiac failure 476 (2.6%) 24 (10.9%) <0.001
Elevated Creatinine >2 mg/dL 1030 (4.9%) 73 (28.4%) <0.001
Stage of kidney disease based on eGFR (mL/min/1.73 m2)
None or 1 8532 (36.5%) 76 (22.4%)
<0.002
2 9874 (42.3%) 69 (20.4%)
3 3481 (14.9%) 77 (22.7%)
4–5 1465 (6.3%) 117 (34.5%)
RDW, median (IQR) 13.4 (12.8–14.3) 15.0 (13.8–17.0) <0.001
Table 1. Characteristics of patients who died within 30-days compared to those alive after 30-days. Legend 
IQR = interquartile range; GA = general anaesthesia; RA = regional anaesthesia; ASA-PS = American Society 
of Anaesthesiologists Physical Status; RCRI = Revised Cardiac Risk Index; eGFR = estimated Glomerular 
Filtration Rate; RDW = Red Cell Distribution Width. Percentages are calculated across the respective rows.
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Incremental effect of RDW and Anaemia on 30-day mortality. As anaemia and higher RDW quar-
tiles were independently associated with 30-day mortality in the multivariate regression analysis, we repeated 
the multivariate logistic regression by stratifying anaemia based on RDW levels (≤15.7% vs >15.7%) to examine 
for any interactions between anaemia and normal or high RDW. We found an incremental effect of high RDW 
(>15.7%) on anaemia in increasing the odds of 30-day mortality (Fig. 3). Strikingly, patients with mild anaemia 
1st quartile 
RDW≤12.8% N = 6540
2nd quartile RDW > 12.8% 
and ≤ 13.4% N = 6025
3rd quartile RDW >13.4% 
and ≤14.3% N = 5286
4th quartile 
RDW > 14.3% N = 5823 P-value
Patient characteristics
Age, median (IQR) 71 (67,75) 72 (68,76) 72 (68,77) 73 (68,78) <0.001
Gender
Male 3142 (27.8%) 2805 (24.8%) 2470 (21.8%) 2904 (25.7%)
0.001
Female 3398 (27.5%) 3220 (26.1%) 2816 (22.8%) 2919 (23.6%)
Race
Chinese 5834 (28.8%) 5270 (26.0%) 4417 (21.8%) 4728 (23.3%)
<0.001
Malay 231 (18.7%) 244 (19.8%) 355 (28.8%) 403 (32.7%)
Indian 212 (19.5%) 241 (22.2%) 278 (25.6%) 356 (32.8%)
Others 263 (23.8%) 270 (24.4%) 236 (21.4%) 336 (30.4%)
Operation details
Priority of Operation
Elective 5503 (28.7%) 5061 (26.4%) 4353 (22.7%) 4270 (22.3%)
<0.001
Emergency 1037 (23.1%) 964 (21.5%) 933 (20.8%) 1553 (34.6%)
Surgical Risk
Low 2778 (30.0%) 2420 (26.1%) 2034 (22.0%) 2024 (21.9%)
<0.001Moderate 3530 (27.1%) 3318 (25.5%) 2945 (22.6%) 3212 (24.7%)
High 232 (16.4%) 287 (20.3%) 307 (21.7%) 587 (41.5%)
Type of Anaesthesia
GA 4538 (27.4%) 4120 (24.9%) 3619 (21.9%) 4259 (25.8%)
<0.001
RA 2002 (28.0%) 1905 (26.7%) 1667 (23.4%) 1564 (21.9%)
Repeat Operations within 
30 days
None 6197 (27.9%) 5718 (25.7%) 4962 (22.3%) 5359 (24.1%)
<0.001
1 or more 343 (23.9%) 307 (21.3%) 324 (22.5%) 464 (32.3%)
Perioperative Packed Red 
Blood Cell Transfusion
0 unit 6245 (29.1%) 5680 (26.5%) 4862 (22.7%) 4677 (21.8%)
<0.0011 unit 288 (16.6%) 320 (18.4%) 378 (21.8%) 751 (43.2%)
2 or more units 7 (1.5%) 25 (5.3%) 46 (9.7%) 395 (83.5%)
Patient characteristics
ASA-PS
1&2 5016 (32.3%) 4353 (28.0%) 3423 (22.0%) 2741 (17.6%)
<0.0013 1270 (18.8%) 1404 (20.8%) 1594 (23.6%) 2490 (36.8%)
4&5 41 (7.7%) 77 (14.5%) 101 (19.0%) 312 (58.8%)
Preoperative Anaemia
None 5054 (35.5%) 4341 (30.5%) 3263 (22.9%) 1596 (11.2%)
<0.001Mild 1064 (21.0%) 1139 (22.5%) 1230 (24.3%) 1636 (32.3%)
Moderate/Severe 422 (9.7%) 545 (12.5%) 793 (18.2%) 2591 (59.5%)
RCRI scores
0 3786 (34.7%) 3051 (28.0%) 2252 (20.7%) 1809 (16.6%)
<0.001
1 1124 (24.4%) 1079 (23.4%) 1028 (22.3%) 1382 (30.0%)
2 238 (16.6%) 285 (19.9%) 331 (23.1%) 580 (40.4%)
3 67 (16.1%) 56 (13.5%) 92 (22.2%) 200 (48.2%)
4–5 12 (10.7%) 13 (11.6%) 24 (21.4%) 63 (56.2%)
Presence of Individual 
components of RCRI




241 (23.3%) 245 (23.7%) 224 (21.7%) 324 (31.3%) <0.001
Diabetes mellitus on 
insulin 172 (20.6%) 176 (21.1%) 170 (20.4%) 315 (37.8%) <0.001
Congestive cardiac 
failure 69 (14.0%) 77 (15.6%) 107 (21.7%) 240 (48.7%) <0.001
Elevated Creatinine 
>2 mg/dL 118 (10.7%) 161 (14.6%) 252 (22.9%) 570 (51.8%) <0.001
Stage of kidney disease based 
on eGFR (mL/min/1.73 m2)
None or 1 2649 (30.9%) 2179 (25.4%) 1774 (20.7%) 1964 (22.9%)
<0.001
2 2968 (30.0%) 2765 (27.9%) 2218 (22.4%) 1944 (19.6%)
3 746 (21.1%) 840 (23.7%) 910 (25.7%) 1043 (29.5)
4–5 151 (9.6%) 220 (13.9%) 361 (22.9%) 847 (53.6%)
30-day mortality
No 6520 (27.9%) 5990 (25.7%) 5212 (22.3%) 5613 (24.1%)
<0.001
Yes 20 (5.9%) 35 (10.3%) 74 (21.8%) 210 (61.9%)
Table 2. Characteristics of patients across RDW quartiles. Legend RDW = Red Cell Distribution Width; 
IQR = interquartile range; GA = general anaesthesia; RA = regional anaesthesia; ASA-PS = American Society 
of Anaesthesiologists Physical Status; RCRI = Revised Cardiac Risk Index; eGFR = estimated Glomerular 
Filtration Rate. Percentages are calculated across the respective rows.
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and high RDW had almost twice the odds of 30-day mortality - aOR 3.00 (1.50–6.03) compared to patients with 
moderate/severe anaemia and normal RDW - aOR 1.70 (1.05–2.77), and similar odds of mortality as moderate/
severe anaemia and high RDW - aOR 3.11 (1.89–5.12). This shows that high RDW has a consistent effect on mor-
tality that is independent of anaemia. Unfortunately, we were unable to demonstrate the effect of high RDW in 
patients with no anaemia due to the small patient numbers (n = 250), which contributed to the wide confidence 
interval of the effect size -aOR 1.51 (0.44–5.16), p = 0.10.
N
Unadjusted OR 
(95% CI) P value
Adjusted OR 
(95% CI) P value
Patient characteristics
Age
65 to 69 years 9201 REF REF
70–75 years 7938 1.81 (1.30–2.50) <0.001 1.25 (0.78–2.00) 0.348
>=76 years 7440 4.10 (3.07–5.49) <0.001 2.41 (1.61–3.63) <0.001
Gender
Male 11671 REF REF
Female 12908 0.67 (0.54–0.82) <0.001 0.94 (0.69–1.27) 0.67
Race
Chinese 20965 REF REF
Malay 1272 2.42 (1.73–3.41) <0.001 1.88 (1.17–3.02) 0.01
Indian 1121 1.25 (0.77–2.02) 0.36 1.26 (0.66–2.43) 0.48
Others 1221 1.34 (0.86–2.10) 0.20 0.99 (0.45–2.20) 0.98
Operation details
Priority of Operation
Elective 20032 REF REF
Emergency 4547 9.61 (7.66–12.05) <0.001 2.99 (2.15–4.14) <0.001
Surgical Risk
Low 9728 REF REF
Moderate 13305 1.49 (1.17–1.91) 0.001 1.87 (1.28–2.71) 0.001
High 1546 3.84 (2.76–5.35) <0.001 1.38 (0.81–2.37) 0.24
Type of Anaesthesia
GA 17355 REF REF
RA 7224 0.68 (0.53–0.88) 0.003 0.72 (0.50–1.04) 0.08
Repeat Operations within 
30 days 1496 3.59 (2.72–4.73) <0.001 2.29 (1.51–3.45) <0.001
Perioperative Packed Red 
Blood Cell Transfusion
0 unit 22294 REF REF
1 unit 1812 5.74 (4.46–7.37) <0.001 1.72 (1.15–2.58) 0.009
2 or more units 473 12.67 (9.17–17.52) <0.001 2.50 (1.51–4.14) <0.001
Patient characteristics
ASA-PS
1&2 16155 REF REF
3 6974 8.69 (6.19–12.18) <0.001 2.79 (1.76–4.43) <0.001
4&5 532 82.50 (56.87–119.68) <0.001 10.07 (5.78–17.55) <0.001
RDW
1st quartile
RDW≤12.8% 6540 REF REF
2nd quartile
RDW>12.8% and≤13.4% 6025 1.91 (1.10–3.30) 0.02 1.31 (0.65–2.64) 0.45
3rd quartile
RDW>13.4% and≤14.3% 5286 4.63 (2.28–7.60) <0.001 2.12 (1.13–3.99) 0.02
4th quartile
RDW>14.3% 5823 12.20 (7.70–19.32) <0.001 2.85 (1.57–5.17) 0.001
Preoperative Anaemia
None 14628 REF REF
Mild 5171 3.20 (2.30–4.47) <0.001 1.44 (0.90–2.29) 0.13
Moderate/Severe 4391 10.58 (8.00–14.01) <0.001 1.61 (1.03–2.53) 0.04
Presence of individual 
components of RCRI
Ischemic heart disease 2712 4.32 (3.29–5.68) <0.001 1.70 (1.22–2.36) 0.002
Previous Cerebrovascular 
accident 1056 2.91 (1.99–4.23) <0.001 1.19 (0.76–1.85) 0.45
Diabetes mellitus on insulin 858 2.92 (1.94–4.40) <0.001 0.82 (0.50–1.36) 0.44
Congestive cardiac failure 500 4.58 (2.97–7.06) <0.001 1.09 (0.66–1.81) 0.73
Stage of kidney disease based 
on eGFR (mL/min/1.73 m2)
None or 1 8608 REF REF
2 9943 0.79 (0.57–1.09) 0.15 0.69 (0.44–1.09) 0.11
3 3558 2.48 (1.80–3.42) <0.001 1.07 (0.68–1.67) 0.78
4–5 1582 8.97 (6.68–12.03) <0.001 2.00 (1.29–3.10) 0.002
Table 3. Table showing results of univariate and multivariate logistic regression of the factors that influence 
30-day mortality in the elderly. Legend ASA-PS = American Society of Anaesthesiologists Physical Status; 
eGFR = estimated Glomerular Filtration Rate; GA = general anaesthesia; IQR = interquartile range; OR = odds 
ratio; RDW = Red Cell Distribution Width; REF = reference; RA = regional anaesthesia; RCRI = Revised 
Cardiac Risk Index.
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Discussion
In this study, we focused on older patients in the perioperative setting and demonstrated that a high RDW per-
centage is independently associated with 30-day all-cause postoperative mortality. This effect of high RDW on 
mortality is more pronounced in patients with anemia, and potentially could be used to improve the accuracy 
of clinical risk predictors. RDW is a simple parameter which reflects the degree of heterogeneity in erythrocyte 
volume and is routinely reported alongside other hematologic indices in the full blood count, which is a common 
blood investigation done prior to surgeries, and is thus available at no additional cost. Prior studies have demon-
strated RDW to be a compelling independent risk factor for longer-term mortality in patients with cardiovascular 
Figure 2. Receiver Operating Curve (ROC) of Red Cell Distribution Width (RDW) in predicting 30-day 
mortality.
Figure 3. Adjusted Odds Ratio (aOR) for various degrees of anaemia stratified by red blood cell distribution 
width (RDW) levels and their 95% Confidence Intervals (CI) plotted on a log scale for the effect of anaemia 





Predictive value Sensitivity Specificity
≥13 (35th) 93.2 31.7 1.9 99.7
≥14 (69th) 70.8 68.2 3.1 99.4
≥15 (84th) 51.0 84.0 4.4 99.2
≥16 (91st) 36.0 91.2 5.6 99.0
≥17 (94th) 25.4 94.5 6.2 98.9
Table 4. Test characteristics of Red Cell Distribution Width for 30-day mortality. Data presented as %. RDW - 
Red cell distribution width.
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diseases such as heart failure, acute myocardial infarction, coronary artery disease, pulmonary embolism, cardiac 
arrest, and stroke11,31–38. A meta-analysis revealed elevated RDW to be associated with aging and the progression 
of various types of disorders, and was also a strong independent predictor of long term survival in the older 
population17. Furthermore, multiple studies support the utilisation of RDW as a biomarker in risk stratification 
for mortality in general populations with or without cardiac diseases, cancer and other frequent comorbidi-
ties5,18,20,31,32,39–41. In the perioperative setting, elevated RDW has been associated with higher risks of one-year 
mortality after surgery19,42,43. Our study supports their finding by demonstrating that RDW also increases peri-
operative mortality in the short term (30-days). This suggests a role for RDW as a useful, cheap and convenient 
biomarker for predicting short term mortality in the perioperative setting.
While the exact biological mechanisms responsible for this association between increased RDW and mortality 
is currently unclear, previous studies suggested oxidative stress44–46, inflammation44,47,48, and malnutrition (such 
as iron, folate or vitamin B12 deficiency) as being the most plausible3. Oxidative stress, a common condition in 
most chronic human disorders, such as cancer, diabetes, heart diseases, liver failure and chronic kidney disease 
is associated with enhanced generation of reactive oxygen species and the consequent damage to nucleic acids, 
proteins and lipids has a profound influence on erythrocyte homeostasis and survival49. Inflammation, on the 
other hand, inhibits bone marrow function and iron metabolism48. Pro-inflammatory cytokines have also been 
determined to inhibit erythropoietin-induced erythrocyte maturation and proliferation and down regulate eryth-
ropoietin receptor expression, all of which increases RDW50,51. Hence, it is plausible that the stressful periopera-
tive period may further increase the oxidative demands and inflammatory load beyond physiological tolerance, 
contributing to the poorer survival.
The presence of preoperative anaemia has been shown to be a strong predictor of postoperative mortality and 
morbidities52–56. Our findings add to current knowledge by demonstrating that high RDW (>15.7%) may further 
increase the odds ratio of 30-day mortality in those with anaemia, especially in patients with moderate/severe 
anaemia. This incremental effect suggests that the underlying reasons for increased RDW also have an impact 
on 30-day postoperative mortality. Admittedly, we were unable to show the impact of high RDW on mortality in 
patients with no anaemia, as we had few patients in our cohort with no anaemia and high RDW (n = 250), which 
may contribute to the wide confidence interval and statistical non-significance (aOR 1.51, 0.44–5.16), p = 0.102). 
Our choice of 15.7% as the cut-off for high versus normal RDW is in between the cut-offs of 14.5–16.0% chosen 
in other studies10,57,58 and was decided upon as it was the upper limit of normal population values validated in 
our laboratory. As shown in our cohort, as well as in other studies, mortality rate is higher in higher RDW quar-
tiles5,39,59. In our study, despite having a study population of elderly patients who are at higher risk of adverse 
outcomes after surgery, the positive predictive value of the highest RDW cut-off of 17% is a mere 6.2%. Thus we 
feel at the choice of 15.7% is a reasonable trade-off between the desired sensitivity of a screening test for at-risk 
patients, yet balanced with a reasonable positive predictive value of 5.3%.
Apart from cost and the ability to standardize a test, an ideal biomarker for risk prediction in a population 
should include qualities such as the test’s independence from established risk factors and ability to extend pre-
dictability beyond current models and generalizability of the results60. Our study demonstrated that RDW was 
an independent risk factor for 30-day mortality in the multivariate analysis, however future studies can be done 
to investigate if the inclusion of RDW could improve the performance of currently available risk stratification 
models.
There is also a need for future studies to deepen the understanding of determinants for RDW, including iden-
tifying reversible factors such as nutritional deficiencies and oxidative stress, which may lead to improved out-
comes after surgery. RDW could be a useful indicator of chronic health state and a practical addition to existing 
risk stratification strategy and shared decision making process.
Limitations. The single-centre, retrospective observational design with short-term follow up are among the 
main limitations of this study. We also did not classify the causes of death and therefore could not examine 
the associations more closely. Furthermore, we did not have comprehensive data that may be associated with 
both RDW and surgical patient outcomes, such as presence of malignancy, underlying haematological disorders, 
nutritional deficiencies, socioeconomic status, and other known or unknown confounders. Therefore, we cannot 
exclude the possibility of residual confounding.
In the absence of a concrete understanding of the mechanism between increased RDW and mortality, it could 
be said that at this point, detecting elevated RDW preoperatively may not necessarily be actionable, despite evi-
dence of its association with short term mortality. However, the strength of using RDW as a prognostic biomarker 
lies with its ready availability at no extra cost, since it is routinely performed as part of a full blood count
Data Availability. Data from this study are available for download from the Dyrad Digital Repository at the 
following https://doi.org/10.5061/dryad.5772v.
Conclusion
Preoperative elevated RDW is an independent predictor of 30-day postoperative mortality among older patients 
undergoing non-cardiac surgery, and has an incremental effect on preoperative anaemia in predicting this risk. 
RDW could be used to improve existing risk stratification strategies and further studies are needed to explore this 
role and the biological process responsible for this association between RDW and mortality.
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